370 results on '"Droogmans, Steven"'
Search Results
52. Head to head comparison of transesophageal and transthoracic contrast-enhanced echocardiography during dobutamine administration for the detection of coronary artery disease
53. Echocardiographic integrated backscatter for the differentiation between aortic valve calcification and valvular myxoid degeneration in rats
54. Dose Dependency and Reversibility of Serotonin-Induced Valvular Heart Disease in Rats
55. Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study
56. Prognostic Value of Coronary Artery Calcium Score in Hospitalized COVID-19 Patients
57. Contrast media iodine concentration in the left ventricle affects the level of radiation-induced DNA damage during CCTA
58. Transcatheter edge-to-edge mitral valve repair as a bridge to optimal guideline-directed medical therapy
59. Possible Association Between 3,4-Methylenedioxymethamphetamine Abuse and Valvular Heart Disease
60. Transcatheter edge-to-edge mitral valve repair as a bridge to optimal guideline-directed medical therapy
61. Feasibility, Reproducibility and Validation of Right Ventricular Volume and Function Assessment Using Three-Dimensional Echocardiography
62. One Year Incidence of Iatrogenic Atrial Septal Defect After Cryoballoon Ablation for Atrial Fibrillation
63. Republished: Drug-induced valvular heart disease
64. Drug-induced valvular heart disease
65. Occurrence of cardiovascular calcifications in normal, aging rats
66. Benfluorex: the last chapter of drug-induced valvular heart disease?
67. Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement
68. Feasibility and Reproducibility of Left Atrium Measurements Using Different Three-Dimensional Echocardiographic Modalities
69. Methylenedioxymethamphetamine-induced toxic valvulopathy
70. Worse Prognosis in Brugada Syndrome Patients With Arrhythmogenic Cardiomyopathy Features
71. Evaluation of contractile function and inotropic reserve with tissue velocity, strain and strain rate imaging in streptozotocin-induced diabetes
72. Valvulopathy in patients treated for hyperprolactinemia?
73. Pericardial effusion in atrial fibrillation ablation: a comparison between cryoballoon and radiofrequency pulmonary vein isolation
74. Analysis of regional wall motion during contrast-enhanced dobutamine stress echocardiography: effect of contrast imaging settings
75. Role of echocardiography in toxic heart valvulopathy
76. Real-life effect and eligibility of ARNI in Belgian HFrEF population
77. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology
78. Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction?
79. Mechanical valve obstructive thrombosis in an asymptomatic patient: a gap in current recommendations.
80. A breath of air during MitraClip valve repair
81. Clinical validation of an ultrasound quantification score for aortic valve calcifications
82. Transcatheter edge-to-edge mitral valve repair as a bridge to optimal guideline-directed medical therapy.
83. Old wine in a new bottle: non-invasive quantitative evaluation of pulmonary congestion with pulmonary blood volume index by cardiac magnetic resonance
84. Speckle tracking echocardiography data in Brugada syndrome patients
85. A breath of air during MitraClip valve repair
86. Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias
87. Spinal cord stimulation as a treatment for refractory neuropathic pain in tethered cord syndrome: a case report
88. Comparison of contrast enhanced three dimensional echocardiography with MIBI gated SPECT for the evaluation of left ventricular function
89. Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats
90. Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study
91. A case report of an unusual cause of mitral stenosis in a young woman
92. A heart-stopping diagnosis
93. Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant ― Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping ―
94. Forethought for using macrophage mannose receptor as target in atherosclerosis
95. Platypnea-orthodeoxia syndrome: an unusual presentation of a complex disease
96. Pulmonary embolism with large oscillating thrombus: an alternative approach
97. Interaction of renal failure and dyslipidaemia in the development of calcific aortic valve disease in rats
98. Prolonged Right Ventricular Ejection Delay in Brugada Syndrome depends on the type of SCN5a mutation. A bridge between Tissue Velocity Imaging and Genetics
99. Prolonged right ventricular ejection delay identifies high risk patients in Brugada Syndrome. Tissue velocity imaging rechallenges risk stratification
100. 18F-Anti-VCAM-1 Nanobody for PET/CT imaging of inflamed atherosclerotic plaque
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.